A Single-center, Open-label, Single-dose Study Investigating the Safety, Tolerability, and Pharmacokinetic Properties of Nalmefene 10 mg Tablets in Healthy Japanese Male Subjects
Clinical trial NCT02679469 · COMPLETED
Trial details
- NCT number
- NCT02679469
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2016-03-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.